Articles
| Open Access |
https://doi.org/10.55640/
METHODOLOGY FOR GROUP PREVENTIVE MEDICAL CONSULTATIONS ON CORONARY ARTERY DISEASE, HYPERTENSION. DISPENSARY OBSERVATION OF PATIENTS WITH CORONARY HEART DISEASE (CHD). DISPENSARY OBSERVATION OF PATIENTS WITH ARTERIAL HYPERTENSION (AH).
Araboyev Shoxrux, Araboyeva Mohirabonu , Andijan State Medical InstituteAbstract
Coronary artery disease (CAD) occurs due to the narrowing or blockage of coronary arteries that supply blood to the heart. The main causes of this disease are as follows:
Keywords
Atherosclerosis, hypertension, coronary artery disease, myocardial infarction, stroke, heart failure, arrhythmia, peripheral artery disease, cholesterol, triglycerides, inflammation, plaque buildup, angina pectoris, risk factors, lifestyle modification, diabetes mellitus, obesity, smoking cessation.
References
Shokhrukhbek, Araboyev. "CULTURAL AND HYGIENE OF PRESCHOOL CHILDREN FORMATION OF QUALIFICATIONS." International journal of scientific researchers (IJSR) INDEXING 5.1 (2024): 221-222.
Shakhrukhbek, Aroboyev, and Abdisalomov Diyorbek. "ATHLETES'DIET." Ethiopian International Journal of Multidisciplinary Research 10.11 (2023): 469-471.
Libby, P., Ridker, P. M., & Hansson, G. K. (2011). Progress and Challenges in Translating the Biology of Atherosclerosis. Nature, 473(7347), 317–325.
Benjamin, E. J., et al. (2019). Heart Disease and Stroke Statistics—2019 Update: A Report from the American Heart Association. Circulation, 139(10), e56–e528.
Ross, R. (1999). Atherosclerosis—An Inflammatory Disease. New England Journal of Medicine, 340(2), 115–126.
Fuster, V., & Kelly, B. B. (Eds.). (2010). Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health. National Academies Press.
Yusuf, S., et al. (2004). Effect of Potentially Modifiable Risk Factors Associated with Myocardial Infarction in 52 Countries (The INTERHEART Study): Case-Control Study. The Lancet, 364(9438), 937–952.
Ridker, P. M., et al. (2017). Anti-Inflammatory Therapy with Canakinumab for Atherosclerotic Disease. New England Journal of Medicine, 377(12), 1119–1131.
WHO. (2021). Cardiovascular Diseases (CVDs) Fact Sheet.
Chow, C. K., et al. (2011). Prevention of Cardiovascular Disease in Clinical Practice: Evidence and Challenges. The Lancet, 378(9792), 587–597.
Article Statistics
Downloads
Copyright License
This work is licensed under a Creative Commons Attribution 4.0 International License.